Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Gastric Ulcers - Overview
Gastric Ulcers - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Gastric Ulcers - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Gastric Ulcers - Companies Involved in Therapeutics Development
Axsome Therapeutics Inc
Daewoong Pharmaceutical Co Ltd
FortuneRock (Chi) Ltd
Hun Mingrui Pharmaceutical Co Ltd
Hun Sailong Pharmaceutical Co Ltd
Jiangsu Aosaikang Pharmaceutical Co Ltd
PharmaKing Co Ltd
RaQualia Pharma Inc
Sam-A Pharm Co Ltd
XuanZhu Pharma Co Ltd
Gastric Ulcers - Drug Profiles
(meloxicam + esomeprazole) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
dexlansoprazole - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
DWJ-1366 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
DWJ-1386 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
DWP-14012 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
KBP-3571 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
pantoprazole sodium - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PMKS-005 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SA-15001 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SFR-9X0123 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Inhibit COX-2 for Gastric Ulcers, Inflammation and Pain - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
tegoprazan - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Gastric Ulcers - Dormant Projects
Gastric Ulcers - Discontinued Products
Gastric Ulcers - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Figure 1: Number of Products under Development for Gastric Ulcers, H2 2019
Figure 2: Number of Products under Development by Companies, H2 2019
Figure 3: Number of Products by Targets, H2 2019
Figure 4: Number of Products by Stage and Targets, H2 2019
Figure 5: Number of Products by Mechanism of Actions, H2 2019
Figure 6: Number of Products by Stage and Mechanism of Actions, H2 2019
Figure 7: Number of Products by Routes of Administration, H2 2019
Figure 8: Number of Products by Stage and Routes of Administration, H2 2019
Figure 9: Number of Products by Molecule Types, H2 2019
Figure 10: Number of Products by Stage and Molecule Types, H2 2019


List of Tables


Table 1: Number of Products under Development for Gastric Ulcers, H2 2019
Table 2: Number of Products under Development by Companies, H2 2019
Table 3: Number of Products under Development by Universities/Institutes, H2 2019
Table 4: Products under Development by Companies, H2 2019
Table 5: Products under Development by Universities/Institutes, H2 2019
Table 6: Number of Products by Stage and Target, H2 2019
Table 7: Number of Products by Stage and Mechanism of Action, H2 2019
Table 8: Number of Products by Stage and Route of Administration, H2 2019
Table 9: Number of Products by Stage and Molecule Type, H2 2019
Table 10: Gastric Ulcers - Pipeline by Axsome Therapeutics Inc, H2 2019
Table 11: Gastric Ulcers - Pipeline by Daewoong Pharmaceutical Co Ltd, H2 2019
Table 12: Gastric Ulcers - Pipeline by FortuneRock (China) Ltd, H2 2019
Table 13: Gastric Ulcers - Pipeline by Hunan Mingrui Pharmaceutical Co Ltd, H2 2019
Table 14: Gastric Ulcers - Pipeline by Hunan Sailong Pharmaceutical Co Ltd, H2 2019
Table 15: Gastric Ulcers - Pipeline by Jiangsu Aosaikang Pharmaceutical Co Ltd, H2 2019
Table 16: Gastric Ulcers - Pipeline by PharmaKing Co Ltd, H2 2019
Table 17: Gastric Ulcers - Pipeline by RaQualia Pharma Inc, H2 2019
Table 18: Gastric Ulcers - Pipeline by Sam-A Pharm Co Ltd, H2 2019
Table 19: Gastric Ulcers - Pipeline by XuanZhu Pharma Co Ltd, H2 2019
Table 20: Gastric Ulcers - Dormant Projects, H2 2019
Table 21: Gastric Ulcers - Discontinued Products, H2 2019